Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Cystic fibrosis gene mutations missing from some cases

16.10.2002


A new study from Johns Hopkins finds that some patients diagnosed with cystic fibrosis (CF) lack any of the more than 1,000 reported disease-causing mutations in the only known CF gene. Scheduled for presentation Oct. 18 at the annual meeting of the American Society for Human Genetics in Baltimore, the findings also recently appeared in the New England Journal of Medicine.



The discovery may mean that another gene, as yet unidentified, is to blame for these cases, or perhaps these patients really have another, unknown disease, despite the similarity of symptoms, the researchers suggest.

Loss of the function of a protein called CFTR was identified more than a decade ago as the cause of CF, a life-shortening disease characterized by frequent, severe lung infections. In less severe cases, known as "non-classic" CF, patients retain some working CFTR, but not at normal levels. Over the years, scientists have linked these conditions to more than 1,000 changes in the gene for CFTR.


"Our findings should lead to a discussion about what is, and is not, non-classic cystic fibrosis," says Garry Cutting, M.D., director of the DNA Diagnostic Lab at the McKusick-Nathans Institute of Genetic Medicine at Hopkins. "Hopefully, extensive clinical evaluation of patients without identifiable changes in the gene for CFTR will improve diagnosis and treatment of cystic fibrosis and cystic fibrosis-like conditions."

In the new study, of 74 patients diagnosed with non-classic CF and referred to the Cystic Fibrosis Foundation Genotyping Center at Hopkins, detailed genetic analysis showed that 29 had mutations in both copies of the CFTR gene, 15 had only a single mutation and 30 had no detectable changes in their CFTR genes. (One copy is inherited from each parent.) Cutting says other researchers now report the same observation.

"These patients were referred by physicians experienced with cystic fibrosis, and we expected to find a causative mutation in each copy of each patient’s CFTR gene," says Cutting, who also heads the genotyping center. "While it’s possible we could have missed some mutations, we believe they just weren’t there to be found in these patients."

The researchers looked for changes in the CFTR gene in areas that carry instructions for the CFTR protein and those that control the expression of the gene. It might be possible that changes to the CFTR protein, unrelated to the sequence of its gene (so-called "epigenetics"), are at the root of these patients’ conditions.

To cause disease, any changes must reduce or alter how the CFTR protein works. In classic CF, there’s no working CFTR protein, and a thick mucous forms that traps bacteria in the airways, causing infections. In the non-classic version, the theory held that some working CFTR protein remained to transport charged atoms and water into and out of cells, while symptoms run the gamut from mild to severe.

First surprised that many patients lacked any mutations in their CFTR genes, the scientists were surprised again when symptoms were the same for these patients and those with one or two CFTR mutations. For each measurement, including the standard test for CFTR function that measures the amount of salt in sweat, each group looked like the others.

"Once we saw that we had a large number of patients without changes in CFTR, we thought we’d be able to demonstrate that they had a different condition," says Cutting. "But we couldn’t."

The Cystic Fibrosis Foundation Genotyping Center at Johns Hopkins was launched in 1998 to look for genetic changes responsible for cases of non-classic cystic fibrosis that couldn’t be explained by the most common known mutations.

The Hopkins researchers are putting together a detailed account of each patient’s symptoms, biochemical and electrophysiological measurements, genetic status, and possible non-genetic contributors to find subtle differences between the groups that will allow physicians to distinguish between conditions linked to CFTR mutations and those that aren’t.

Joanna Downer | EurekAlert!
Further information:
http://www.ashg.org
http://www.nejm.org

More articles from Health and Medicine:

nachricht Cholesterol-lowering drugs may fight infectious disease
22.08.2017 | Duke University

nachricht Once invincible superbug squashed by 'superteam' of antibiotics
22.08.2017 | University at Buffalo

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

Cholesterol-lowering drugs may fight infectious disease

22.08.2017 | Health and Medicine

Meter-sized single-crystal graphene growth becomes possible

22.08.2017 | Materials Sciences

Repairing damaged hearts with self-healing heart cells

22.08.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>